Document:

EX-10.14

 Exhibit 10.14 

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT 

This FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT (the “Amendment”) is made and entered into effective as of February 1, 2021
(the “Effective Date”), by and between BioTelemetry, Inc., a Delaware corporation (formerly Cardionet, Inc.) (“Company”), and Heather Getz (“Executive”). Company and Executive are referred to herein collectively as the
“Parties” and individually as a “Party”. 
 WITNESSETH: 

WHEREAS, the Parties have entered into the Employment Agreement (the “Agreement”) effective the 15th day of January, 2010;

 WHEREAS, Section 10 of the Agreement provides that the Agreement may be amended only by written agreement executed by both
Parties; and 
 WHEREAS, the Parties desire to amend the Agreement in certain respects as hereinafter specified. 

NOW THEREFORE, in consideration of the foregoing recitals and the mutual promises and covenants made herein, the Parties agree as
follows: 
 1. Section 4.5.3(i) of the Agreement shall be amended and restated to read as follows: 

“(i) payment of (a) an amount equal to one and one-half times (1.5x) Executive’s annual
Base Salary in effect at the time of termination (but determined prior to any reduction in Base Salary that would give rise to Executive’s right to voluntarily resign for “Good Reason” pursuant to Section 4.6.2), less required
deductions and withholdings, and (b) an amount equal to one and one-half times (1.5x) Executive’s on-target annual performance incentive bonus in effect at the
time of termination, less required deductions and withholdings, such amounts described in (a) and (b) hereof to be paid in installments over twelve (12) months following the date of Executive’s termination in accordance with the
Company’s payroll practices commencing within sixty (60) days of the date of Executive’s termination;” 
 2. Section
4.5.3(iii) of the Agreement shall be amended and restated to read as follows: 
 “(iii) continued participation in the medical, dental
and vision plans in which Executive (and where applicable, Executive’s spouse and dependents) was enrolled as of the date of Executive’s termination until the earlier of: (a) the date that is eighteen (18) months after the date
of Executive’s termination, or (b) the date upon which Executive becomes eligible to enroll in any similar plan offered 

  
 Page 1 of 3 

 
or provided by an employer other than the Company, at the same premium rates and cost sharing as may be charged from time to time for employees generally, as if Executive had continued in
employment during such period. Executive agrees to immediately notify the Company in writing in the event Executive becomes eligible to so enroll.” 

3. All other terms and obligations in the Agreement shall remain unchanged and in full force and effect. 

[Remainder of Page Intentionally Left Blank] 

  
 Page 2 of 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed effective
as of the Effective Date. 
  

									
	COMPANY:	 		 		 	EXECUTIVE:
				
	BioTelemetry, Inc.	 		 		 	Heather Getz
					
	By:	 	 /s/ Joseph H. Capper
	 		 	    	 	 /s/ Heather Getz

	Name: Joseph H. Capper	 		 		 	
	Title: President and Chief Executive Officer	 		 		 	
				
	Date of Execution: February 1, 2021	 		 		 	Date of Execution: February 1, 2021
				
	Address for Notices to Company:	 		 		 	Address for Notices to Executive:
				
	 BioTelemetry, Inc.
 1000 Cedar
Hollow Road
 Malvern, Pennsylvania
 19355
	 		 		 	 Heather Getz
 c/o BioTelemetry, Inc.

1000 Cedar Hollow Road
 Malvern, Pennsylvania

19355

  
 Page 3 of 3EX-10.15

 Exhibit 10.15 

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT 

This FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT (the “Amendment”) is made and entered into effective as of February 1, 2021
(the “Effective Date”), by and between BioTelemetry, Inc., a Delaware corporation (formerly Cardionet, Inc.) (“Company”), and Fred A. Broadway III (“Executive”). Company and Executive are referred to herein collectively
as the “Parties” and individually as a “Party”. 
 WITNESSETH: 

WHEREAS, the Parties have entered into the Employment Agreement (the “Agreement”) effective the 30th day of July, 2010; 

WHEREAS, Section 10 of the Agreement provides that the Agreement may be amended only by written agreement executed by both
Parties; and 
 WHEREAS, the Parties desire to amend the Agreement in certain respects as hereinafter specified. 

NOW THEREFORE, in consideration of the foregoing recitals and the mutual promises and covenants made herein, the Parties agree as
follows: 
 1. Section 4.5.3(i) of the Agreement shall be amended and restated to read as follows: 

“(i) payment of (a) an amount equal to one and one-half times (1.5x) Executive’s annual
Base Salary in effect at the time of termination (but determined prior to any reduction in Base Salary that would give rise to Executive’s right to voluntarily resign for “Good Reason” pursuant to Section 4.6.2), less required
deductions and withholdings, and (b) an amount equal to one and one-half times (1.5x) Executive’s on-target annual performance incentive bonus in effect at the
time of termination, less required deductions and withholdings, such amounts described in (a) and (b) hereof to be paid in installments over twelve (12) months following the date of Executive’s termination in accordance with the
Company’s payroll practices commencing within sixty (60) days of the date of Executive’s termination;” 
 2. Section
4.5.3(iii) of the Agreement shall be amended and restated to read as follows: 
 “(iii) continued participation in the medical, dental
and vision plans in which Executive (and where applicable, Executive’s spouse and dependents) was enrolled as of the date of Executive’s termination until the earlier of: (a) the date that is eighteen (18) months after the date
of Executive’s termination, or (b) the date upon which Executive becomes eligible to enroll in any similar plan offered 

  
 Page 1 of 3 

 
or provided by an employer other than the Company, at the same premium rates and cost sharing as may be charged from time to time for employees generally, as if Executive had continued in
employment during such period. Executive agrees to immediately notify the Company in writing in the event Executive becomes eligible to so enroll.” 

3. All other terms and obligations in the Agreement shall remain unchanged and in full force and effect. 

[Remainder of Page Intentionally Left Blank] 

  
 Page 2 of 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed effective
as of the Effective Date. 
  

							
	COMPANY:	  		  	EXECUTIVE:
			
	BioTelemetry, Inc.	  		  	Fred A. Broadway III
				
	By:	  	 /s/ Joseph H. Capper
	  	    	  	 /s/ Fred A. Broadway III

	Name: Joseph H. Capper	  		  	
	Title: President and Chief Executive Officer	  		  	
			
	 Date of Execution: February 1, 2021
  

Address for Notices to Company:
	  		  	Date of Execution: February 1, 2021
	  		  	Address for Notices to Executive:
			
	 BioTelemetry, Inc.
 1000 Cedar
Hollow Road
 Malvern, Pennsylvania
 19355
	  	 

            

 
	  	 Fred A. Broadway III
 c/o BioTelemetry, Inc.

1000 Cedar Hollow Road
 Malvern, Pennsylvania

19355

  
 Page 3 of 3Exhibit 10.1

 

CONFIDENTIALITY AND LOCKUP AGREEMENT

 

This Confidentiality
and Lockup Agreement is dated as of January 31, 2021 and is between Otonomo Technologies Ltd., a company organized under the laws
of the State of Israel (the “Company”), and each of the shareholder parties identified on Exhibit A
hereto and the other persons who enter into a joinder to this Agreement substantially in the form of Exhibit D hereto
with the Company in order to become a “Shareholder Party” for purposes of this Agreement (collectively, the “Shareholder
Parties”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Business
Combination Agreement (as defined below).

 

BACKGROUND:

 

WHEREAS, the
Shareholder Parties own or will own equity interests in Software Acquisition Group Inc. II, a Delaware corporation (“SPAC”),
and/or the Company;

 

WHEREAS, pursuant
to that certain Business Combination Agreement, dated as of January 31, 2021 (as it may be amended, supplemented, restated or otherwise
modified from time to time, the “Business Combination Agreement”), by and among the Company, SPAC and
Butterbur Merger Sub Inc., a Delaware corporation and a direct, wholly owned subsidiary of the Company (“Merger Sub”),
Merger Sub will merge with and into SPAC, with SPAC continuing as the surviving entity and a wholly-owned subsidiary of the Company
(the “Merger”); and

 

WHEREAS, in
connection with the Merger and effective upon the consummation thereof, the parties hereto wish to set forth herein certain understandings
between such parties with respect to confidentiality and restrictions on transfer of equity interests in the Company.

 

NOW, THEREFORE,
the parties agree as follows:

 

ARTICLE I

INTRODUCTORY MATTERS

 

1.1 Defined Terms.
In addition to the terms defined elsewhere herein, the following terms have the following meanings when used herein with initial
capital letters:

 

“Agreement”
means this Confidentiality and Lockup Agreement, as the same may be amended, supplemented, restated or otherwise modified from
time to time in accordance with the terms hereof.

 

“Company”
has the meaning set forth in the Preamble.

 

“Company
Ordinary Shares” means ordinary shares of no par value of the Company.

 

“Confidential
Information” means any information concerning the Company or its Subsidiaries that is furnished after the date of
this Agreement by or on behalf of the Company or its designated representatives to a Shareholder Party or its designated representatives,
together with any notes, analyses, reports, models, compilations, studies, documents, records or extracts thereof containing, based
upon or derived from such information, in whole or in part; provided, however, that Confidential Information does
not include information:

 

(i) that
is generally known to the public at the time of disclosure or becomes generally known without violation of this Agreement by the
receiving Shareholder Party or its designated representatives;

 

     

     

    

 

(ii) that
is in the Shareholder Party’s possession or the possession of the Shareholder Party’s representatives at the time of
disclosure otherwise than as a result of Shareholder Party’s or its designated representatives’ breach of any legal
or fiduciary obligation of confidentiality owed to the Company or its affiliates;

 

(iii) that
becomes known to the receiving Shareholder Party or its designated representatives through disclosure by sources, other than the
Company, provided that such sources are not known by the receiving Shareholder Party to be bound by a confidentiality agreement
with, or other contractual, legal, or fiduciary obligation of confidentiality to, the Company or its affiliates with respect to
such information;

 

(iv) that
is independently developed by the receiving Shareholder Party or its designated representatives without use of or reference to
the Confidential Information; or

 

(v) that
the receiving Shareholder Party or its designated representatives is required, in the good faith determination of such receiving
Shareholder Party or designated representative, to disclose by applicable Law, regulation or legal process, provided that such
receiving Shareholder Party or designated representative takes reasonable steps to minimize the extent of any such required disclosure,
discloses only that portion of the Confidential Information that such Shareholder Party’s legal counsel advises is legally
required to be disclosed, and, if permissible, provides the Company with the opportunity to seek a protective order or other appropriate
remedy to prevent such disclosure, provided further that no such steps to minimize disclosure shall be required where disclosure
is made in connection with a routine audit or examination by a bank examiner or auditor and such audit or examination does not
specifically reference the Company or this Agreement.

 

“covered
shares” has the meaning set forth in Section 3.1.

 

“designated
representatives” means, with respect to a Shareholder Party, (a) its and its Affiliates’ directors, managers,
officers, attorneys, accountants, consultants, insurers, financing sources and other advisors in connection with such Shareholder
Party’s investment in the Company and (b) any of such Shareholder Party’s or their respective Affiliates’ partners,
members, shareholders, directors, managers, officers, other fiduciaries, employees or agents in the ordinary course of business,
so long as such Person has agreed to maintain the confidentiality of the information relating to the Company provided to it.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder,
as the same may be amended from time to time.

 

“immediate
family” has the meaning set forth in Section 3.1(b).

 

    2

     

    

 

“Letter
Agreement” means the Letter Agreement, dated September 14, 2020, by and among SPAC, the Sponsor and the other signatories
thereto.

 

“Lock-Up
Period” has the meaning set forth in Section 3.1(a).

 

“Major
Holders” means Bessemer Venture Partners IX L.P., Bessemer Venture Partners IX Institutional L.P. , Stage One Venture
Capital Fund II (Israel) L.P. and Stage One Venture Capital Fund II (Cayman) L.P.

 

“Non-Recourse
Party” means any past, present or future director, officer, employee, incorporator, member, partner, stockholder,
Affiliate, agent, attorney, advisor or representative or Affiliate of any named party to this Agreement and any past, present or
future director, officer, employee, incorporator, member, partner, stockholder, Affiliate, agent, attorney, advisor or representative
or Affiliate of any of the foregoing.

 

“Permitted
Transferees” means with respect to a Shareholder Party, a transferee of shares that agrees to become party to, and
to be bound to the same extent as its Transferor by the terms of, this Agreement.

 

“Private
Placement Warrants” means the warrants to purchase shares of Class A common stock, par value $0.0001 per share, of
SPAC issued pursuant to the Private Placement Warrant Purchase Agreement, dated as of September 14, 2020, by and between SPAC and
the Sponsor, and any shares of the Company issued in respect thereof.

 

“shares”
means Company Ordinary Shares received by the Sponsor and any of its Permitted Transferees pursuant to the Business Combination
Agreement and the Company Ordinary Shares held by the other Shareholder Parties immediately following the Merger.

 

“Sponsor”
means Software Acquisition Holdings II LLC, a Delaware limited liability company.

 

“Shareholder
Parties” has the meaning set forth in the Preamble.

 

1.2 Construction.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and
no rule of strict construction will be applied against any party. Unless the context otherwise requires: (a) “or”
is disjunctive but not exclusive, (b) words in the singular include the plural, and in the plural include the singular, and
(c) the words “hereof”, “herein”, and “hereunder” and words of similar import when used
in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement, and Section references
are to sections of this Agreement unless otherwise specified.

 

    3

     

    

 

ARTICLE II

CONFIDENTIALITY

 

2.1 Confidentiality.
Each Shareholder Party agrees that it will, and will direct its designated representatives to, keep confidential and not disclose
any Confidential Information; provided, however, that the Sponsor and the Major Holders may disclose Confidential
Information (a) to its designated representatives and (b) as the Company may otherwise consent in writing; provided,
further, however, that each Shareholder Party agrees to be responsible for any breaches of this Article II
by such Shareholder Party’s designated representatives and agrees, at its sole expense, to take commercially reasonable measures
(including, but not limited to, court proceedings) to restrain its designated representatives from prohibited or unauthorized disclosure
of the Confidential Information.

 

ARTICLE III

LOCKUP

 

3.1 Lockup.
(a) (i) In the case of each Shareholder Party listed on Exhibit B hereto, during the period beginning on the Closing Date
and continuing to and including the date that is 180 days after the Closing Date, and (ii) in the case of each Shareholder Party
listed on Exhibit C hereto, during the period beginning on the Closing Date and continuing to and including the date that
is the earlier of (A) one year after the Closing Date and (B) if the last sale price of the Company Ordinary Shares equals or exceeds
$12.00 per share (to be adjusted appropriately in the event the Company does not effect a stock split prior to the Effective Time
in order to cause the Company Share Value to equal $10.00) (as adjusted after the Closing for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the
Closing Date (in each case, the “Lock-Up Period”), each such Shareholder Party agrees not to, directly
or indirectly, offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of
any shares, or any options or warrants to purchase any shares (other than the Private Placement Warrants and Ordinary Shares underlying
the Private Placement Warrants), or any securities convertible into, exchangeable for or that represent the right to receive shares,
or any interest in any of the foregoing, whether now owned or hereinafter acquired, owned directly by the undersigned (including
holding as a custodian) or with respect to which the undersigned has beneficial ownership within the rules and regulations of the
U.S. Securities and Exchange Commission (collectively, the “covered shares”). The foregoing restriction
is expressly agreed to preclude such Shareholder Parties from engaging in any hedging or other transaction which is designed to
or which reasonably could be expected to lead to or result in a sale or disposition of the covered shares even if such covered
shares would be disposed of by someone other than such Shareholder Parties. Such prohibited hedging or other transactions would
include, without limitation, any short sale or any purchase, sale or grant of any right (including, without limitation, any put
or call option) with respect to any of the covered shares or with respect to any security that includes, relates to, or derives
any significant part of its value from such covered shares.

 

    4

     

    

 

(b) Notwithstanding
the foregoing, a Shareholder Party may transfer or dispose of its shares following the Closing (i) by will or intestacy, (ii) as
a bona fide gift or gifts, including to charitable organizations, (iii) to any trust, partnership, limited liability company
or other entity for the direct or indirect benefit of the undersigned or the immediate family of the undersigned (for purposes
of this Section 3.1, “immediate family” shall mean any relationship by blood, current or
former marriage or adoption, not more remote than first cousin), (iv) to any immediate family member or other dependent, (v) as
a distribution to limited partners, members or shareholders of such Shareholder Party, (vi) to its Affiliated investment fund,
other Affiliated entity controlled by, any account managed by, or designee of, such Shareholder Party or its or their Affiliates,
(vii) to a nominee or custodian of a Person to whom a disposition or transfer would be permissible under clauses (i) through
(vi) above, (viii) pursuant to an order or decree of a Governmental Entity, (ix) to the Company or its Subsidiary or
parent entities upon death, disability or termination of employment, in each case, of such holder, (x) pursuant to a bona
fide tender offer, merger, consolidation or other similar transaction in each case made to all holders of the shares involving
a Change of Control (as defined below) (including negotiating and entering into an agreement providing for any such transaction),
provided that in the event that such tender offer, merger, consolidation or other such transaction is not completed, such Shareholder
Party’s shares shall remain subject to the provisions of this Section 3.1, (xi) to the Company (1) pursuant
to the exercise, in each case on a “cashless” or “net exercise” basis, of any option to purchase shares
granted by the Company pursuant to any employee benefit plans or arrangements which are set to expire during the Lock-Up Period,
where any shares received by the undersigned upon any such exercise will be subject to the terms of this Section 3.1,
or (2) for the purpose of satisfying any withholding taxes (including estimated taxes) due as a result of the exercise of
any option to purchase shares or the vesting of any restricted stock awards granted by the Company pursuant to employee benefit
plans or arrangements which are set to expire or automatically vest during the Lock-Up Period, in each case on a “cashless”
or “net exercise” basis, where any shares received by such Shareholder Party upon any such exercise or vesting will
be subject to the terms of this Section 3.1, or (xii) in any transaction relating to Ordinary Shares acquired by the
undersigned in open market transactions; or (xiii) with the prior written consent of the Company; provided that:

 

(1) in the
case of each transfer or distribution pursuant to clauses (ii) through (vii) above, (a) each donee, trustee, distributee or
transferee, as the case may be, agrees to be bound in writing by the restrictions set forth in this Section 3.1; and
(b) any such transfer or distribution shall not involve a disposition for value, other than with respect to any such transfer
or distribution for which the transferor or distributor receives (x) equity interests of such transferee or (y) such
transferee’s interests in the transferor;

 

(2) in the
case of each transfer or distribution pursuant to clauses (ii) through (vii) above, if any public reports or filings (including
filings under Section 16(a) of the Exchange Act) reporting a reduction in beneficial ownership of shares shall be required
or shall be voluntarily made during the Lock-Up Period (x) such Shareholder Party shall provide the Company prior written
notice informing them of such report or filing and (y) such report or filing shall disclose that such donee, trustee, distributee
or transferee, as the case may be, agrees to be bound in writing by the restrictions set forth herein; and

 

(3) for purposes
of clause (x) above, “Change of Control” shall mean the transfer to or acquisition by (whether by
tender offer, merger, consolidation, division or other similar transaction), in one transaction or a series of related transactions,
a Person or group of Affiliated Persons (other than an underwriter pursuant to an offering), of the Company’s voting securities
if, after such transfer or acquisition, such Person or group of Affiliated Persons would Beneficially Own more than 50% of the
outstanding voting securities of the Company (or the surviving entity).

 

(c) Each Shareholder
Party shall be permitted to enter into a trading plan established in accordance with Rule 10b5-1 under the Exchange Act during
the applicable Lock-Up Period so long as no transfers or other dispositions of such Shareholder Party’s shares in contravention
of Section 3.1 are effected prior to the expiration of the applicable Lock-Up Period.

 

    5

     

    

 

(d) Each Shareholder
Party also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar
against the transfer of the covered shares except in compliance with the foregoing restrictions and to the addition of a legend
to such Shareholder Party’s shares describing the foregoing restrictions.

 

(e) If the Company
enters into a lockup agreement or similar arrangement (or any amendment thereof or waiver thereof, except as set forth in Section
4.3(b) with respect to lock-up releases) in respect of the Merger (other than the Sponsor Letter Agreement or any arrangement
in connection with the PIPE Financing) with any other person, including any other Company shareholder, that contains any provision
that is more favorable to such other person than the provisions of this Agreement (a “More Favorable Agreement”),
the Company shall promptly provide the Shareholder Parties with notice thereof and a copy of such provision, and upon such notice,
this Agreement shall be deemed to be amended to conform the provisions of this Agreement with such more favorable provision.

 

(f) Any Company Ordinary
Shares acquired by the undersigned pursuant to any subscription agreement executed in connection with the PIPE Financing shall
not be subject to the lockup provisions of this Section 3.

 

(g) For the avoidance
of doubt, the lockup provisions of this Section 3 shall not prevent the undersigned from selling Company Ordinary Shares
pursuant to the Secondary Purchase Agreement.

 

3.2 Termination
of Founder Shares Lockup. At the Effective Time, the Letter Agreement shall be deemed amended to replace paragraph 7(a)
thereof with “[reserved]”.

 

ARTICLE IV

GENERAL PROVISIONS

 

4.1 Termination.
Subject to Section 4.13 or the early termination of any provision as a result of an amendment to this Agreement agreed
to by the Company Board and the Shareholder Parties, as provided under Section 4.3, this Agreement shall not terminate
with respect to a Shareholder Party or its Permitted Transferees until the expiration of the Lock-Up Period.

 

4.2 Notices.
All notices, requests, claims, demands and other communications among the parties shall be in writing and shall be deemed to have
been duly given (i) when delivered in person, (ii) when delivered after posting in the United States mail having been sent registered
or certified mail return receipt requested, postage prepaid, (iii) when delivered by FedEx or other nationally recognized overnight
delivery service or (iv) when e-mailed during normal business hours (and otherwise as of the immediately following Business Day),
addressed as follows:

 

If to the Company, to:

 

Otonomo Technologies Ltd.

16 Abba Eban Blvd.

Herzliya 4672534, Israel

	Attention:	Ben Volkow
	 	Bonnie Moav
	Email:	ben@otonomo.io
	 	bonnie@otonomo.io

 

    6

     

    

 

with copies (which shall not constitute
notice) to:

 

Latham & Watkins LLP

811 Main Street, Suite 3700

Houston, Texas 77002

	Attention:	Ryan Maierson
	 	John Greer
	E-mail:	ryan.maierson@lw.com
	 	john.greer@lw.com

 

Latham & Watkins LLP

99 Bishopsgate

London EC2M 3XF

United Kingdom

	Attention:	Joshua Kiernan
	E-mail:	joshua.kiernan@lw.com

 

If to SPAC, to:

 

Software Acquisition Holdings Inc. II

1980 Festival Plaza Drive, Suite 300

Las Vegas, Nevada 89135

	Attention:	Jonathan Huberman
	Email:	jon@softwareaqn.com

 

with a copy (which shall not constitute notice)
to :

 

Kirkland & Ellis LLP

601 Lexington Avenue

New York, New York 10022

	Attention:	Christian Nagler
	 	Brooks Antweil
	Email:	cnagler@kirkland.com
	 	brooks.antweil@kirkland.com

 

If to any Shareholder Party, to such address indicated on the Company’s records with respect to such Shareholder Party or
to such other address or addresses as such Shareholder Party may from time to time designate in writing.

 

4.3 Amendment;
Waiver; Pro Rata Release. (a) The terms and provisions of this Agreement may be amended or modified in whole or in part
only by a duly authorized agreement in writing executed by the Company and Shareholder Parties holding a majority of the shares
then held by the Shareholder Parties in the aggregate as to which this Agreement has not been terminated pursuant to Section 4.1.

 

    7

     

    

 

(b) In the event that a release is granted
to any Shareholder Party relating to the lock-up restrictions set forth in Article III above, the same percentage of the undersigned’s
Company Ordinary Shares (the “Pro-Rata Release”) shall be immediately and fully released on the same terms from
any remaining lock-up restrictions set forth herein; provided that no Pro-Rata Release shall be required for any release
approved by the Board of Directors of the Company.

 

(c) Except as expressly
set forth in this Agreement, neither the failure nor delay on the part of any party hereto to exercise any right, remedy, power
or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy
power or privilege preclude any other or further exercise of the same or of any other right, remedy, power or privilege, nor shall
any waiver of any right, remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy,
power or privilege with respect to any other occurrence.

 

(d) No party shall
be deemed to have waived any claim arising out of this Agreement, or any right, remedy, power or privilege under this Agreement,
unless the waiver of such claim, right, remedy, power or privilege is expressly set forth in a written instrument duly executed
and delivered on behalf of such party; and any such waiver shall not be applicable or have any effect except in the specific instance
in which it is given.

 

(e) Any party hereto
may unilaterally waive any of its rights hereunder in a signed writing delivered to the Company.

 

4.4 Further Assurances.
The parties hereto will sign such further documents, cause such meetings to be held, resolutions passed, exercise their votes and
do and perform and cause to be done such further acts and things necessary, proper or advisable in order to give full effect to
this Agreement and every provision hereof. To the fullest extent permitted by Law, the Company shall not directly or indirectly
take any action that is intended to, or would reasonably be expected to result in, the Shareholder Parties being deprived of the
rights contemplated by this Agreement.

 

4.5 Assignment.
No party shall assign, delegate, or otherwise transfer this Agreement or any part hereof without the prior written consent of the
other parties hereto. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective permitted successors and assigns. Any attempted assignment in violation of the terms of this Section 4.5
shall be null and void, ab initio.

 

4.6 Third Parties.
Except as provided for in Article II, Article III and Article IV with respect to any Non-Recourse Party, nothing
expressed or implied in this Agreement is intended or shall be construed to confer upon or give any Person, other than the parties
hereto, any right or remedies under or by reason of this Agreement.

 

4.7 Governing
Law. This Agreement, and all claims or causes of action based upon, arising out of, or related to this Agreement, shall
be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application
of the law of any jurisdiction other than the State of Delaware.

 

    8

     

    

 

4.8 Jurisdiction;
Waiver of Jury Trial.

 

(a) Each of the parties
hereto irrevocably and unconditionally submits to the exclusive jurisdiction of the Chancery Court of the State of Delaware (or,
if the Chancery Court of the State of Delaware declines to accept jurisdiction, any state or federal court sitting in the Borough
of Manhattan, State of New York, New York County), for the purposes of any Proceeding (as defined in the Business Combination Agreement),
claim, demand, action or cause of action (a) arising under this Agreement or (b) in any way connected with or related or incidental
to the dealings of the parties hereto in respect of this Agreement, and irrevocably and unconditionally waives any objection to
the laying of venue of any such Proceeding in any such court, and further irrevocably and unconditionally waives and agrees not
to plead or claim in any such court that any such Proceeding has been brought in an inconvenient forum. Each party hereby irrevocably
and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Proceeding,
claim, demand, action or cause of action against such Party (i) arising under this Agreement or (ii) in any way connected with
or related or incidental to the dealings of the parties hereto in respect of this Agreement, (A) any claim that such party
is not personally subject to the jurisdiction of the courts as described in this Section 4.8 for any reason, (B) that
such party or such party’s property is exempt or immune from the jurisdiction of any such court or from any legal process
commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment,
execution of judgment or otherwise) and (C) that (x) the Proceeding, claim, demand, action or cause of action in any
such court is brought against such party in an inconvenient forum, (y) the venue of such Proceeding, claim, demand, action
or cause of action against such party is improper or (z) this Agreement, or the subject matter hereof, may not be enforced
against such party in or by such courts. Each party agrees that service of any process, summons, notice or document by registered
mail to such party’s respective address set forth in Section 4.8 shall be effective service of process for any
such Proceeding, claim, demand, action or cause of action.

 

(b) THE PARTIES HERETO
EACH HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY PROCEEDING, CLAIM, DEMAND, ACTION,
OR CAUSE OF ACTION (I) ARISING UNDER THIS AGREEMENT OR UNDER ANY ANCILLARY DOCUMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED
OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND
WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE.  THE PARTIES HERETO EACH HEREBY AGREES AND CONSENTS THAT ANY SUCH PROCEEDING,
CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES HERETO MAY FILE AN
ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE
WAIVER OF THEIR RIGHT TO TRIAL BY JURY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF
ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER, (B) EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH SUCH PARTY MAKES
THIS WAIVER VOLUNTARILY AND (D) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL
WAIVERS AND CERTIFICATIONS IN THIS SECTION 4.8.

 

    9

     

    

 

4.9 Specific
Performance. The parties hereto each agree that irreparable damage for which monetary damages, even if available, would
not be an adequate remedy, would occur in the event that the parties hereto do not perform their obligations under the provisions
of this Agreement in accordance with its specified terms or otherwise breach such provisions. The parties acknowledge and agree
that (a) the parties shall be entitled to an injunction, specific performance, or other equitable relief, to prevent breaches of
this Agreement and to enforce specifically the terms and provisions hereof, without proof of damages, prior to the valid termination
of this Agreement, and (b) the right of specific enforcement is an integral part of the transactions contemplated by this Agreement
and without that right, none of the parties would have entered into this Agreement. Each party agrees that it will not oppose the
granting of specific performance and other equitable relief on the basis that the other parties have an adequate remedy at law
or that an award of specific performance is not an appropriate remedy for any reason at law or equity. The parties hereto each
acknowledge and agree that any party seeking an injunction to prevent breaches of this Agreement and to enforce specifically the
terms and provisions of this Agreement in accordance with this Section 4.9 shall not be required to provide any bond or
other security in connection with any such injunction.

 

4.10 Severability.
Whenever possible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable
Law, but if any term or other provision of this Agreement is held to be invalid, illegal or unenforceable under applicable Law,
all other provisions of this Agreement shall remain in full force and effect so long as the economic or legal substance of the
transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any
term or other provision of this Agreement is invalid, illegal or unenforceable under applicable Law, the parties hereto shall negotiate
in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in an acceptable
manner in order that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible.

 

4.11 Entire Agreement.
This Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes
all other prior agreements and understandings, both written and oral, among the parties hereto with respect to the subject matter
hereof.  No representations, warranties, covenants, understandings, agreements, oral or otherwise, with respect to the subject
matter contemplated by this Agreement exist between the parties hereto except as expressly set forth or referenced in this Agreement.

 

4.12 Captions;
Counterparts. The headings, subheadings and captions contained in this Agreement are inserted for convenience only and
shall not affect in any way the meaning or interpretation of this Agreement. This Agreement and any amendment hereto may be executed
in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same
agreement. Delivery of an executed counterpart of a signature page to this Agreement or any amendment hereto by electronic means,
including docusign, e-mail, or scanned pages shall be effective as delivery of a manually executed counterpart to this Agreement
or any amendment hereto.

 

    10

     

    

 

4.13 Effectiveness;
Termination if Business Combination Agreement is Terminated. This Agreement shall be valid and enforceable as of the date
of this Agreement and may not be revoked by any party hereto; provided that the provisions herein (other than this Article IV)
shall not be effective until the consummation of the Merger. In the event the Business Combination Agreement is terminated in accordance
with its terms, this Agreement shall automatically terminate and be of no further force or effect.

 

4.14 Non-Recourse.
This Agreement may only be enforced against, and any claim or cause of action based upon, arising out of, or related to this Agreement
or the transactions contemplated hereby may only be brought against, the entities that are expressly named as parties hereto, and
then only with respect to the specific obligations set forth herein with respect to such party. Except to the extent a named party
to this Agreement (and then only to the extent of the specific obligations undertaken by such named party in this Agreement), no
Non-Recourse Party shall have any liability (whether in contract, tort, equity or otherwise) for any one or more of the representations,
warranties, covenants, agreements or other obligations or liabilities of the parties to this Agreement or for any claim based on,
arising out of, or related to this Agreement or the transactions contemplated hereby.

 

4.15
Conflicts. In the event of any conflict or inconsistency between the terms and conditions of
this Agreement and the terms and conditions with respect to transfer restrictions on shares of the Company set forth
in the Company A&R Articles of Association, the terms and conditions set forth in this Agreement shall prevail.

 

[Remainder of Page Intentionally Left
Blank]

 

    11

     

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Confidentiality and Lockup Agreement on the day and year first above written.

 

	 	otonomo Technologies Ltd.
	 	 	 
	 	By:	/s/ Ben Volkow
	 	 	Name: Ben Volkow
	 	 	Title: CEO

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	Software Acquisition Holdings II LLC
	 	 	 
	 	By:	/s/ Jonathan S. Huberman
	 	 	Name: Jonathan S. Huberman
	 	 	Title: Managing Member

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	By:	/s/ Jonathan S. Huberman
	 	 	Name: Jonathan S. Huberman

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	By:	/s/ Stephanie Davis
	 	 	Name: Stephanie Davis

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	By:	/s/ Steven Guggenheimer
	 	 	Name: Steven Guggenheimer

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	By:	/s/ Mike Nikzad
	 	 	Name: Mike Nikzad

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	By:	/s/ C. Matthew Olton
	 	 	Name: C. Matthew Olton

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	By:	/s/ Andrew K. Nikou
	 	 	Name: Andrew K. Nikou

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	By:	/s/ Peter H. Diamandis
	 	 	Name: Peter H. Diamandis

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	BEN VOLKOW
	 	 	 
	 	By:	/s/ Ben Volkow

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	BONNIE MOAV  
	 	 	 
	 	By:	/s/ Bonnie Moav  

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	SHLOMI OREN  
	 	 	 
	 	By:	/s/ Shlomi Oren  

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	HAGIT TENNE PEREG  
	 	 	 
	 	By:	/s/ Hagit Tenne-Pereg

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	MATAN TESSLER  
	 	 	 
	 	By:	/s/ Matan Tessler  

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	ASAF WEISBROT  
	 	 	 
	 	By:	/s/ Asaf Weisbrot  

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	Alliance Ventures  
	 	 	 
	 	By:	/s/ Hadi Zablit
	 	 	Name: Hadi Zablit 
	 	 	Title: Alliance Ventures Chairman

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	Aptiv International Holdings (Luxembourg) S.à.r.l  
	 	 	 
	 	By:	/s/ David M. Sherbin  
	 	 	Name: David M. Sherbin   
	 	 	Title: Director  

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	Yuval Cohen as Proxy for
    Avner Cohen by Proxy dated November 24, 2017  
	 	 	 
	 	By:	/s/ Yuval Cohen  
	 	 	Name: Yuval Cohen  

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

BESSEMER VENTURE PARTNERS IX L.P.

BESSEMER VENTURE PARTNERS IX INSTITUTIONAL L.P.

 

By: Deer IX & Co. L.P., their General Partner

By: Deer IX & Co. Ltd., its General Partner

 

	By:	/s/ Scott Ring	 
	 	Scott Ring, General Counsel	 

 

Notice Address:

 

c/o Bessemer Venture Partners

1865 Palmer Avenue

Suite 104

Larchmont, NY 10538

Tel. 914-833-5300

Transactions@bvp.com

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	STAGE ONE VENTURE CAPITAL FUND II (CAYMAN), L.P.  
	 	 	 
	 	By:	/s/ Yuval Cohen, /s/ Tal Slobodkin  
	 	 	Name: Yuval Cohen, Tal Slobodkin  
	 	 	Title: Managing Partners  

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

	 	STAGE ONE VENTURE CAPITAL FUND II (ISRAEL), L.P.
	 	 	 
	 	By:	 /s/ Yuval Cohen, /s/ Tal Slobodkin
	 	 	Name: Yuval Cohen, Tal Slobodkin
	 	 	Title: Managing Partners

 

[Signature Page to Confidentiality and
Lockup Agreement]

 

     

     

    

 

Exhibit A

 

Software Acquisition Holdings II LLC

Ben Volkow

Bessemer Venture Partners IX L.P.

Bessemer Venture Partners IX Institutional L.P.

Stage One Venture Capital Fund II (Israel) L.P.

Stage One Venture Capital Fund II (Cayman) L.P.

Alliance Ventures

Aptiv International Holdings (Luxembourg) S.à.r.l.

Avner Cohen

Asaf Weisbrot

Bonnie Moav

Hagit Tenne-Pereg

Matan Tessler

Shlomi Oren

Jonathan S. Huberman

Mike Nikzad

Andrew K. Nikou

C. Matthew Olton

Stephanie Davis

Steven Guggenheimer

Peter H. Diamandis

 

     

     

    

 

Exhibit B

 

Bessemer Venture Partners IX L.P.

Bessemer Venture Partners IX Institutional L.P.

Stage One Venture Capital Fund II (Israel) L.P.

Stage One Venture Capital Fund II (Cayman) L.P.

Alliance Ventures

Aptiv International Holdings (Luxembourg) S.à.r.l.

Avner Cohen

 

     

     

    

 

Exhibit C

 

Software Acquisition Holdings II LLC

Ben Volkow

Asaf Weisbrot

Bonnie Moav

Hagit Tenne-Pereg

Matan Tessler

Shlomi Oren

Jonathan S. Huberman

Mike Nikzad

Andrew K. Nikou

C. Matthew Olton

Stephanie Davis

Steven Guggenheimer

Peter H. Diamandis

 

     

     

    

 

Exhibit D

 

FORM OF JOINDER TO CONFIDENTIALITY AND LOCKUP AGREEMENT

 

[______], 20__

 

Reference is made to the Confidentiality
and Lockup Agreement, dated as of [ ● ], 2021, by and among Otonomo Technologies Ltd. (the “Company”)
and the other Shareholder Parties (as defined therein) from time to time party thereto (as amended from time to time, the “Confidentiality
and Lockup Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to
such terms in the Confidentiality and Lockup Agreement.

 

Each of the Company and each undersigned
holder of ordinary shares of the Company (each, a “New Shareholder Party”) agrees that this Joinder to the Confidentiality
and Lockup Agreement (this “Joinder”) is being executed and delivered for good and valuable consideration.

 

Each undersigned New Shareholder Party
hereby agrees to and does become party to the Confidentiality and Lockup Agreement as a Shareholder Party. This Joinder shall serve
as a counterpart signature page to the Confidentiality and Lockup Agreement and by executing below each undersigned New Shareholder
Party is deemed to have executed the Confidentiality and Lockup Agreement with the same force and effect as if originally named
a party thereto.

 

This Joinder may be executed in multiple
counterparts, including by means of facsimile or electronic signature, each of which shall be deemed an original, but all of which
together shall constitute the same instrument.

 

[Remainder of Page Intentionally Left
Blank.]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned have
duly executed this Joinder as of the date first set forth above.

 

	 	[NEW SHAREHOLDER PARTY]
	 	 	 
	 	By:	 
	 	 	Name: 
	 	 	Title 
	 	 	 
	 	Otonomo Technologies Ltd.
	 	 	 
	 	By:	                      
	 	 	Name: 
	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]